News
Important Only
Micron Beats Fiscal Q2 Expectations
Micron Technology (NASDAQ:MU), a leading innovator in memory and storage solutions, reported its fiscal 2025 second-quarter results on March 20. Revenue increased significantly year over year to $8.05 billion, and non-GAAP EPS came in at $1.56, surpassing analysts' consensus estimates for revenue of...The Motley Fool
Thu, Mar 20
Phunware Inc reports results for the quarter ended December 31 - Earnings Summary
Phunware Inc PHUN.OQ reported a quarterly adjusted loss of 6 cents per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $-4.62. The mean expectation of three analysts for the quarter was for a loss of 19 cents per share. Wall Street...Reuters
Thu, Mar 20
Vor Biopharma Inc reports results for the quarter ended December 31 - Earnings Summary
Vor Biopharma Inc VOR.OQ reported a quarterly adjusted loss of 44 cents per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -39 cents. The mean expectation of seven analysts for the quarter was for a loss of 29 cents per share. Wall...Reuters
Thu, Mar 20
Nike Q3 EPS Outperforms, Revenue Down 9%
Sports apparel giant Nike (NYSE:NKE) reported fiscal 2025 third-quarter results on Thursday, March 20, that topped analysts' consensus estimates. Earnings per share (EPS) of $0.54 exceeded expectations of $0.30. Revenue beat projections at $11.27 billion but fell 9% year over year. Overall, the quar...The Motley Fool
Thu, Mar 20
Intellicheck Inc reports results for the quarter ended December 31 - Earnings Summary
Intellicheck Inc IDN.OQ reported quarterly adjusted earnings of 2 cents per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of 4 cents. The mean expectation of four analysts for the quarter was for a loss of one cent per share. Wall St...Reuters
Thu, Mar 20
Skye Bioscience Inc reports results for the quarter ended December 31 - Earnings Summary
Skye Bioscience Inc SKYE.OQ reported a quarterly adjusted loss of 24 cents per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -63 cents. The mean expectation of six analysts for the quarter was for a loss of 28 cents per share. Wa...Reuters
Thu, Mar 20
ACELYRIN Inc reports results for the quarter ended December 31 - Earnings Summary
ACELYRIN Inc SLRN.OQ reported a quarterly adjusted loss of 79 cents per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -97 cents. The mean expectation of three analysts for the quarter was for a loss of 86 cents per share. Wall St...Reuters
Thu, Mar 20
Creative Medical Technology Holdings Inc reports results for the quarter ended December 31 - Earnings Summary
Creative Medical Technology Holdings Inc CELZ.OQ reported a quarterly adjusted loss of $1.12 per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $-1.19. The lone analyst forecast for the quarter was for a loss of 63 cents per share...Reuters
Thu, Mar 20
Vaxart Inc reports results for the quarter ended December 31 - Earnings Summary
Vaxart Inc VXRT.OQ reported a quarterly adjusted loss of 5 cents per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -12 cents. The mean expectation of three analysts for the quarter was for a loss of 10 cents per share. Wall Stree...Reuters
Thu, Mar 20
Torrid Holdings Inc reports results for the quarter ended January 31 - Earnings Summary
Torrid Holdings Inc CURV.N reported a quarterly adjusted loss of 3 cents per share for the quarter ended January 31, higher than the same quarter last year, when the company reported EPS of -4 cents. The mean expectation of five analysts for the quarter was for a loss of 6 cents per share. Wall S...Reuters
Thu, Mar 20
TELA Bio Inc reports results for the quarter ended December 31 - Earnings Summary
TELA Bio Inc TELA.OQ reported a quarterly adjusted loss of 23 cents per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -53 cents. The mean expectation of five analysts for the quarter was for a loss of 22 cents per share. Wall Str...Reuters
Thu, Mar 20
Nike Inc reports results for the quarter ended February 28 - Earnings Summary
Nike Inc NKE.N reported quarterly adjusted earnings of 54 cents per share for the quarter ended February 28, lower than the same quarter last year, when the company reported EPS of 77 cents. The mean expectation of twenty five analysts for the quarter was for earnings of 29 cents per share. Wall ...Reuters
Thu, Mar 20
MacroGenics Inc reports results for the quarter ended December 31 - Earnings Summary
MacroGenics Inc MGNX.OQ reported a quarterly adjusted loss of 25 cents per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -75 cents. The mean expectation of eight analysts for the quarter was for a loss of 44 cents per share. Wall...Reuters
Thu, Mar 20
Flux Power Holdings Inc reports results for the quarter ended December 31 - Earnings Summary
Flux Power Holdings Inc FLUX.OQ reported a quarterly adjusted loss of 11 cents per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -5 cents. The mean expectation of three analysts for the quarter was for a loss of 11 cents per share...Reuters
Thu, Mar 20
Amprius Technologies Inc reports results for the quarter ended December 31 - Earnings Summary
Amprius Technologies Inc AMPX.N reported a quarterly adjusted loss of 10 cents per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -11 cents. The mean expectation of eight analysts for the quarter was for a loss of 11 cents per sha...Reuters
Thu, Mar 20
Arcadia Biosciences Inc reports results for the quarter ended December 31 - Earnings Summary
Arcadia Biosciences Inc RKDA.OQ reported a quarterly adjusted loss of $2.99 per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of $-2.52. The lone analyst forecast for the quarter was for a loss of 89 cents per share. Revenue rose 3.9...Reuters
Thu, Mar 20
Scholastic Corp reports results for the quarter ended February 28 - Earnings Summary
Scholastic Corp SCHL.OQ reported a quarterly adjusted loss of 5 cents per share for the quarter ended February 28, higher than the same quarter last year, when the company reported EPS of -87 cents. The lone analyst forecast for the quarter was for a loss of 78 cents per share. Revenue rose 3.6% ...Reuters
Thu, Mar 20
Luminar Technologies Inc reports results for the quarter ended December 31 - Earnings Summary
Luminar Technologies Inc LAZR.OQ reported a quarterly adjusted loss of $1.42 per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $-3.00. The mean expectation of five analysts for the quarter was for a loss of $2.18 per share. Wall ...Reuters
Thu, Mar 20
TRADING DAY-No direction Jerome
By Jamie McGeever ORLANDO, Florida, March 20 (Reuters) - TRADING DAY Post-Fed rally fades, global caution mounts U.S. markets struggled for clear direction on Thursday, as investors cooled some of their optimism around Federal Reserve Chair Jerome Powell's view that the economy is in good...Reuters
Thu, Mar 20
